Ankur Pandey

General Manager/ CEO (Vietnam), STADA Pymepharco

As of April 6, 2026, Ankur Pandey officially joined STADA Pymepharco as General Manager – Vietnam and as a member of STADA Emerging Markets Leadership Team.

Based in Ho Chi Minh City, he is responsible for leading the company’s growth strategy and further strengthening its position in one of Southeast Asia’s most dynamic healthcare markets.

With over 18 years of experience in the pharmaceutical and healthcare industry, Ankur brings strong leadership capabilities, deep market expertise, and a proven track record in driving commercial growth, strategic development, and market expansion across Southeast Asia, including Vietnam, Myanmar, Singapore, and Malaysia.

Ankur most recently served as Vice President Vietnam at DKSH, where he led strategic initiatives across general management, commercial operations, and business development. Prior to this, he held multiple senior leadership roles within DKSH across Myanmar and Singapore, overseeing large-scale operations, managing full P&L responsibilities, and driving commercial excellence across diverse healthcare portfolios .

He began his career at Torrent Pharmaceuticals, where he held key roles in international business and country management, contributing to market expansion and establishing a strong presence across Southeast Asia and other emerging markets .

Recognized for his ability to lead high-performing teams and execute transformation strategies with a strong focus on culture and performance, Ankur shares: “Throughout my career, collaboration, agility, and entrepreneurship have been my guiding principles as a leader, and I will continue to uphold these values in this new role. I look forward to concluding with the team a transformative journey in the most dynamic markets in Southeast Asia”.

Under his leadership, STADA Pymepharco will continue to strengthen organizational capabilities and expand access to high-quality, “German standard” healthcare solutions for the community.